MX9804051A - Metodo enzimatico y composiciones para tratar la sangre hemorragica intravitrea. - Google Patents
Metodo enzimatico y composiciones para tratar la sangre hemorragica intravitrea.Info
- Publication number
- MX9804051A MX9804051A MX9804051A MX9804051A MX9804051A MX 9804051 A MX9804051 A MX 9804051A MX 9804051 A MX9804051 A MX 9804051A MX 9804051 A MX9804051 A MX 9804051A MX 9804051 A MX9804051 A MX 9804051A
- Authority
- MX
- Mexico
- Prior art keywords
- compositions
- enzymatic method
- blood
- hemorrhagic blood
- vitreous humor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7016—Disaccharides, e.g. lactose, lactulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
Una preparacion de hialuronidasa libre de timerosal en donde la enzima hialuronidasa preferida carece de fracciones de peso molecular abajo de 40,000, entre 60-70,000, y arriba de 100,000. También se describe un método para acelerar la limpieza de la sangre hemorrágica del humor vítreo del ojo, el método comprende poner en contacto al menos una enzima de limpieza de hemorragia (por ejemplo, beta-glucoronidasa, metaloproteínasa de matriz, condroitinasa, condroitin sulfatasa, o protein quinasa) con el humor vítreo en una cantidad la cual es efectiva para provocar la limpieza acelerada de la sangre a partir de los mismos.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/561,636 US5866120A (en) | 1995-11-22 | 1995-11-22 | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
Publications (1)
Publication Number | Publication Date |
---|---|
MX9804051A true MX9804051A (es) | 1998-12-31 |
Family
ID=24242789
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX9804051A MX9804051A (es) | 1995-11-22 | 1998-05-21 | Metodo enzimatico y composiciones para tratar la sangre hemorragica intravitrea. |
Country Status (15)
Country | Link |
---|---|
US (5) | US5866120A (es) |
EP (1) | EP0862456B1 (es) |
JP (1) | JP2000502325A (es) |
KR (1) | KR100463009B1 (es) |
CN (1) | CN1207684A (es) |
AT (1) | ATE298584T1 (es) |
AU (1) | AU1407097A (es) |
BR (1) | BR9611617A (es) |
CA (1) | CA2238360C (es) |
DE (1) | DE69634903T2 (es) |
DK (1) | DK0862456T3 (es) |
ES (1) | ES2245458T3 (es) |
MX (1) | MX9804051A (es) |
PT (1) | PT862456E (es) |
WO (1) | WO1997018835A1 (es) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6610292B2 (en) | 1995-11-22 | 2003-08-26 | Ista Pharmaceuticals, Inc. | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
US5866120A (en) * | 1995-11-22 | 1999-02-02 | Advanced Corneal Systems, Inc. | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
EP0983084B1 (en) * | 1997-05-22 | 2007-01-10 | Ista Pharmaceuticals, Inc. | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
KR20010041806A (ko) | 1998-03-09 | 2001-05-25 | 에드워드 에이취. 댄스 | 효소 각막교정술에 사용되는 각막 경화제의 용도 |
US7008960B1 (en) | 1999-03-02 | 2006-03-07 | Vitreo-Retinal Technologies, Inc. | Agents for intravitreal administration to treat or prevent disorders of the eye |
WO2000056354A2 (en) | 1999-03-22 | 2000-09-28 | Boston Innovative Optics, Inc. | Methods of using agents that act on the epithelial sheet of a human eye |
AU4672300A (en) * | 1999-04-29 | 2000-11-17 | Ista Pharmaceuticals, Inc | Biochemical methods that eliminate corneal scars, opacification and haze |
AU4511201A (en) | 1999-12-03 | 2001-06-12 | Ista Pharmaceuticals, Inc | Compositions and methods for the induction and treatment of retinal detachments |
US7977385B2 (en) * | 2000-03-02 | 2011-07-12 | Numoda Biotechnologies, Inc. | Agents for corneal or intrastromal administration to treat or prevent disorders of the eye |
US20030199574A1 (en) | 2000-03-02 | 2003-10-23 | Vitreo-Retinal Technologies, Inc. | Treatment of ophthalmic disorders using urea and urea derivatives |
US7141607B1 (en) | 2000-03-10 | 2006-11-28 | Insite Vision Incorporated | Methods and compositions for treating and inhibiting retinal neovascularization |
US6902548B1 (en) * | 2001-03-19 | 2005-06-07 | Ed Schuler | Use of Streptomyces hyalurolyticus enzyme in ophthalmic treatments |
US6745776B2 (en) | 2001-04-10 | 2004-06-08 | David B. Soll | Methods for reducing postoperative intraocular pressure |
US7115408B1 (en) | 2001-05-02 | 2006-10-03 | Ista Pharmaceuticals, Inc. | Method of stabilizing hyaluronidase with annexin II |
CA2455827C (en) * | 2001-08-13 | 2015-06-09 | University Of Florida Research Foundation, Inc. | Materials and methods for nerve grafting comprising degrading chondroitin sulfate proteoglycan |
ATE481478T1 (de) * | 2002-06-03 | 2010-10-15 | Massachusetts Inst Technology | Rationell konstruierte, von chondroitinase b abgeleitete lyasen |
US20050137124A1 (en) * | 2002-08-09 | 2005-06-23 | Vitreo-Retinal Technologies, Inc. A California Corporation | Agents for intravitreal administration to treat or prevent disorders of the eye |
GB0228409D0 (en) * | 2002-12-06 | 2003-01-08 | Thromb X Nv | Pharmacological vitreolysis |
MXJL02000046A (es) * | 2002-12-13 | 2004-06-24 | Jimenez Bayardo Arturo | Solucion inyectable intravitrea para el tratamiento de hemorragias vitreas. |
US6969514B2 (en) | 2003-02-05 | 2005-11-29 | Soll David B | Method for treating elevated intraocular pressure, including glaucoma |
US8012115B2 (en) | 2003-02-18 | 2011-09-06 | S.K. Pharmaceuticals, Inc. | Optic nerve implants |
WO2004092361A1 (en) * | 2003-04-15 | 2004-10-28 | Ista Pharmaceuticals, Inc. | Process for isolating and purifing ovine hyaluronidase |
MXPA03011987A (es) | 2003-12-19 | 2005-06-23 | Osio Sancho Alberto | Metodo para el tratamiento de la presbicia induciendo cambios en el poder y fisiologia corneal. |
WO2005118799A1 (en) * | 2004-04-15 | 2005-12-15 | Ista Pharmaceuticals, Inc. | Ovine hyaluronidase |
PL1817347T3 (pl) * | 2004-11-24 | 2017-10-31 | Albumedix As | Sposób sieciowania kwasu hialuronowego za pomocą diwinylosulfonu |
US20090286289A1 (en) * | 2008-03-10 | 2009-11-19 | Pang Danny Z | Production of Hyaluronate Unsaturated Disaccharides and its Application |
CN102266348A (zh) * | 2011-08-04 | 2011-12-07 | 山西诺成制药有限公司 | 一种眼内冲洗液及其制备方法 |
RU2647783C2 (ru) | 2012-08-10 | 2018-03-19 | Осио Корпорейшн Д/Б/А Иолиа Хелт | Использование контактных линз при лечении офтальмологического нарушения |
US8784896B2 (en) | 2012-09-17 | 2014-07-22 | Biopep Solutions, Inc | Antioxidant therapy with a whole, leech saliva extract |
KR101454646B1 (ko) | 2012-11-05 | 2014-10-27 | (주)한국비엠아이 | 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제 |
US20140212404A1 (en) * | 2012-11-14 | 2014-07-31 | Khizer Khaderi | Compositions and Methods for Treating Injuries to the Visual System of a Human |
TW202202168A (zh) * | 2020-07-07 | 2022-01-16 | 洪啟庭 | 用於改善玻璃體混濁的組成物及其應用 |
CN113769073A (zh) * | 2021-10-15 | 2021-12-10 | 杭州鑫伟低碳技术研发有限公司 | 一种利用生物酶治疗眼底出血的方法 |
Family Cites Families (45)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US37336A (en) * | 1863-01-06 | Improvement in hooped skirts | ||
FR6256M (es) * | 1967-01-26 | 1968-08-19 | ||
US3728223A (en) | 1971-10-08 | 1973-04-17 | Amano Pharma Co Ltd | Production of hyaluronidase from a strain of streptomyces |
JPS5413510B2 (es) | 1973-08-28 | 1979-05-31 | ||
US4141973A (en) * | 1975-10-17 | 1979-02-27 | Biotrics, Inc. | Ultrapure hyaluronic acid and the use thereof |
US4174389A (en) * | 1977-05-13 | 1979-11-13 | Cope Louise A | Ophthalmic use of collagenase |
JPS6033474B2 (ja) | 1978-05-11 | 1985-08-02 | 藤沢薬品工業株式会社 | 新規なヒアルロニダ−ゼbmp−8231およびその製造法 |
US4490351A (en) * | 1982-03-15 | 1984-12-25 | Children's Hospital Medical Center | Methods of treating disorders of an eye with liquid perfluorocarbons |
US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
US4474751A (en) * | 1983-05-16 | 1984-10-02 | Merck & Co., Inc. | Ophthalmic drug delivery system utilizing thermosetting gels |
US5316926A (en) | 1983-11-25 | 1994-05-31 | Miles Inc. | Method for the microbiological production of non-antigenic hyaluronic acid |
GB8504025D0 (en) * | 1985-02-16 | 1985-03-20 | Biopharm Ltd | Hyaluronidase |
US4757089A (en) * | 1985-06-14 | 1988-07-12 | Massachusetts Eye And Ear Infirmary | Increasing aqueous humor outflow |
FR2588189B1 (fr) * | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
SE456245B (sv) | 1986-07-09 | 1988-09-19 | Pharmacia Ab | Enzympreparation innehallande krillhyaluronidas |
FR2608045B1 (fr) * | 1986-12-12 | 1990-03-02 | Chauvin Laboratoires | Utilisation d'inhibiteurs de xanthine- oxydase, de piegeurs de radicaux libres oxygenes et de chelateurs du fer pour la fabrication d'une composition pharmaceutique destinee au traitement du glaucome et compositions pharmaceutiques destinees au traitement du glaucome |
NO164844C (no) | 1988-10-24 | 1990-11-21 | Norsk Hydro As | Fremgangsmaate ved utvinning av enzymer fra krepsdyr. |
US5013714A (en) * | 1988-12-15 | 1991-05-07 | Lindstrom Richard L | Viscoelastic solution |
US5260059A (en) * | 1989-04-14 | 1993-11-09 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon Health Sciences University | Treatment of open-angle glaucoma by modulation matrix metalloproteinases and their inhibitor |
US4897349A (en) | 1989-04-28 | 1990-01-30 | Medchem Products, Inc. | Biosynthesis of hyaluronic acid |
US5015577A (en) | 1989-08-29 | 1991-05-14 | Board Of Regents, The University Of Texas System | DNA encoding hyaluronate synthase |
FR2657018A1 (fr) * | 1990-01-12 | 1991-07-19 | Merck Sharp & Dohme | Composition ophtalmique fluide a base de microparticules lipidiques contenant au moins un principe actif et son procede de preparation. |
ZA912770B (en) * | 1990-04-16 | 1992-01-29 | Bethesda Eye Inst | Enzymatic disinsertion of vitreous body |
US5300295A (en) * | 1990-05-01 | 1994-04-05 | Mediventures, Inc. | Ophthalmic drug delivery with thermoreversible polyoxyalkylene gels adjustable for pH |
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
US5077033A (en) * | 1990-08-07 | 1991-12-31 | Mediventures Inc. | Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide |
US5270051A (en) * | 1991-10-15 | 1993-12-14 | Harris Donald H | Enzyme-orthokeratology |
US5318780A (en) * | 1991-10-30 | 1994-06-07 | Mediventures Inc. | Medical uses of in situ formed gels |
JP2948708B2 (ja) * | 1991-11-27 | 1999-09-13 | ニューヨーク・ブラッド・センター・インコーポレーテッド | フィブロネクチン含有点眼液 |
US5188331A (en) * | 1991-12-06 | 1993-02-23 | Baines Gurney D | Umbrella support bracket |
US5758552A (en) * | 1992-02-05 | 1998-06-02 | Myers; Harry T. | Tool handle safety plate |
US5242961A (en) * | 1992-05-28 | 1993-09-07 | Shell Oil Company | Color prevention in titanium catalyzed hydrogenated diene polymers |
FI933264A (fi) * | 1992-07-21 | 1994-01-22 | Hoechst Roussel Pharma | Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin |
US5593877A (en) | 1993-03-11 | 1997-01-14 | The Rockefeller University | Nucleic acid and recombinant production of vespid venom hyaluronidase |
US5496726A (en) | 1993-04-16 | 1996-03-05 | Lucky Limited | Streptococcus zooepidemicus medium and process for preparing hyaluronic acid |
EP0782850A4 (en) | 1994-10-13 | 1998-03-04 | Wakamoto Pharma Co Ltd | LYOPHILIZED PREPARATION FOR PRODUCING A REVERSIBLE THERMOGELING MEDICINAL WATER-BASED |
US5747027A (en) | 1995-04-07 | 1998-05-05 | The Regents Of The University Of California | BH55 hyaluronidase |
US6610292B2 (en) * | 1995-11-22 | 2003-08-26 | Ista Pharmaceuticals, Inc. | Use of hyaluronidase in the manufacture of an ophthalmic preparation for liquefying vitreous humor in the treatment of eye disorders |
US5866120A (en) * | 1995-11-22 | 1999-02-02 | Advanced Corneal Systems, Inc. | Method for accelerating clearance of hemorrhagic blood from the vitreous humor with hyaluronidase |
US5866964A (en) | 1996-01-29 | 1999-02-02 | Emerson Electric Company | Reluctance machine with auxiliary field excitations |
US6123938A (en) | 1996-10-17 | 2000-09-26 | The Regents Of The University Of California | Human urinary hyaluronidase |
DE19726626C1 (de) | 1997-06-17 | 1998-09-03 | Pharma Dessau Gmbh | Verfahren zur Herstellung eines eine Hyaluronidase enthaltenden Präparats |
US5868120A (en) * | 1997-06-30 | 1999-02-09 | Siemens Canada Limited | Fuel vapor management system for motor vehicles |
DK1048725T3 (da) | 1999-04-27 | 2005-08-22 | Transgene Sa | Fremgangsmåde til fremstilling af pattedyrcellelinjer |
SK17612001A3 (sk) | 1999-06-12 | 2002-04-04 | Merck Patent Gmbh | Hyaluronidáza z Hirudinaria manillensis, jej izolácia, čistenie a rekombinantné spôsoby jej výroby |
-
1995
- 1995-11-22 US US08/561,636 patent/US5866120A/en not_active Expired - Lifetime
-
1996
- 1996-11-20 BR BR9611617A patent/BR9611617A/pt not_active IP Right Cessation
- 1996-11-20 PT PT96944203T patent/PT862456E/pt unknown
- 1996-11-20 AT AT96944203T patent/ATE298584T1/de active
- 1996-11-20 JP JP9519951A patent/JP2000502325A/ja active Pending
- 1996-11-20 AU AU14070/97A patent/AU1407097A/en not_active Abandoned
- 1996-11-20 ES ES96944203T patent/ES2245458T3/es not_active Expired - Lifetime
- 1996-11-20 DE DE69634903T patent/DE69634903T2/de not_active Expired - Lifetime
- 1996-11-20 KR KR10-1998-0703840A patent/KR100463009B1/ko not_active IP Right Cessation
- 1996-11-20 WO PCT/US1996/018843 patent/WO1997018835A1/en active IP Right Grant
- 1996-11-20 EP EP96944203A patent/EP0862456B1/en not_active Expired - Lifetime
- 1996-11-20 CA CA002238360A patent/CA2238360C/en not_active Expired - Lifetime
- 1996-11-20 DK DK96944203T patent/DK0862456T3/da active
- 1996-11-20 CN CN96199746A patent/CN1207684A/zh active Pending
-
1998
- 1998-05-21 MX MX9804051A patent/MX9804051A/es unknown
- 1998-08-24 US US09/139,282 patent/US6039943A/en not_active Expired - Lifetime
-
1999
- 1999-12-02 US US09/453,012 patent/US6551590B2/en not_active Expired - Lifetime
-
2003
- 2003-02-14 US US10/369,372 patent/US6939542B2/en not_active Expired - Fee Related
-
2005
- 2005-08-15 US US11/204,636 patent/US20060034822A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2000502325A (ja) | 2000-02-29 |
CA2238360A1 (en) | 1997-05-29 |
EP0862456B1 (en) | 2005-06-29 |
US6939542B2 (en) | 2005-09-06 |
US5866120A (en) | 1999-02-02 |
CA2238360C (en) | 2009-09-01 |
AU1407097A (en) | 1997-06-11 |
ES2245458T3 (es) | 2006-01-01 |
KR100463009B1 (ko) | 2005-02-28 |
DE69634903T2 (de) | 2006-05-18 |
US20020071837A1 (en) | 2002-06-13 |
PT862456E (pt) | 2005-11-30 |
US6551590B2 (en) | 2003-04-22 |
US6039943A (en) | 2000-03-21 |
KR19990071565A (ko) | 1999-09-27 |
US20060034822A1 (en) | 2006-02-16 |
CN1207684A (zh) | 1999-02-10 |
US20030129182A1 (en) | 2003-07-10 |
EP0862456A1 (en) | 1998-09-09 |
WO1997018835A1 (en) | 1997-05-29 |
ATE298584T1 (de) | 2005-07-15 |
DK0862456T3 (da) | 2005-10-17 |
BR9611617A (pt) | 1999-04-06 |
EP0862456A4 (en) | 2003-02-12 |
DE69634903D1 (de) | 2005-08-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX9804051A (es) | Metodo enzimatico y composiciones para tratar la sangre hemorragica intravitrea. | |
Prehm | Synthesis of hyaluronate in differentiated teratocarcinoma cells. Characterization of the synthase | |
Huber et al. | β-D-glucan hydrolase activity in Zea coleoptile cell walls | |
Klein et al. | Partial purification and characterization of a heparan sulfate specific endoglucuronidase | |
EP0885955A3 (en) | Thermostable purified endoglucanases from thermophilic bacterium acidothermus cellulolyticus | |
AU1916899A (en) | Alpha-interferon-polymer-conjugates having enhanced biological activity and methods of preparing the same | |
IE881150L (en) | Low molecular weight heparins of regular structure, their¹preparation and their biological uses | |
EP1621082A3 (en) | Process and an enzyme for use in such a process | |
TW354756B (en) | A process for the non-random cleavage of starch | |
DK0832250T3 (da) | Mutant alfa-amylase | |
EP0576592A4 (en) | Oligosaccharide enzyme substrates and inhibitors: methods and compositions | |
Yamamoto et al. | Partial purification and properties of phleinase induced in stem base of orchardgrass after defoliation | |
IL114643A0 (en) | Recombinant thermostable enzyme which releases trehalose from non-reducing saccharide and its preparation | |
Shiomi et al. | Purification and properties of sucrose: sucrose 1F-β-D-fructosyltransferase in onion seeds | |
Hamai et al. | Purification and characterization of hyaluronidase from Streptococcus dysgalactiae | |
IL114637A0 (en) | Recombinant thermostable enzyne which forms non-reducing saccharide from reducing amylaceous saccharide and its preparation | |
EP1118667A4 (en) | NOVEL ENZYME COMPOSITIONS, PROCESS FOR PRODUCING SUCH COMPOSITIONS, AND USE THEREOF | |
Heifetz et al. | Biosynthesis of cell-surface sulfated glycoproteins by cultured vascular endothelial cells | |
Lomako et al. | The substrate specificity of isoamylase and the preparation of apo-glycogenin | |
WO1999046368A3 (en) | Carbohydrate-modifying enzymes for burn and wound debridement and methods for treatment | |
Pfeiler | Isolation and partial characterization of a novel keratan sulfate proteoglycan from metamorphosing bonefish (Albula) larvae | |
AU570574B2 (en) | Depolymerase enzymes and treatment of fireblight | |
GB9424331D0 (en) | Manufacture of vitreous fibre products | |
Nakamura et al. | A new type of exo-beta-glucuronidase acting only on non-sulfated glycosaminoglycans. | |
Peeters-Joris et al. | A direct simultaneous plate assay of proteoglycan and collagen degradation by cells in culture and its application to synovial cells |